Infectious side effects of cancer treatment in children. Clinical and genetic aspects
PhD ceremony: Ms. E.M. te Poele, 14.30 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Infectious side effects of cancer treatment in children. Clinical and genetic aspects
Promotor(s): prof. E.S.J.M de Bont, prof. W.A. Kamps
Faculty: Medical Sciences
Chemotherapy has significantly improved the survival of children with cancer. One of the side effects of chemotherapy is the inhibited production of white blood cells. This effect predisposes for infections and infectious complications. Therefore, fever during neutropenia (lack of a specific type of white blood cells) is treated with intravenous antibiotics. The first part of this thesis deals with clinical issues. We examined the possibilities for a better risk assessment of fever during neutropenia to prevent overtreatment of patients with a low risk for bacterial infections. This cost-efficient approach may contribute to a better quality of life.
Subsequently, we studied the number of infectious deaths during the ALL-9 protocol (treatment for acute lymphoblastic leukemia (ALL) in children). We found an increase in the number of infectious deaths compared to previous protocols. This is most probably caused by repeated, prolonged treatment with the drug Dexamethasone in ALL-9. Furthermore, the use of Pegfilgrastim was evaluated. This medicine may be administered to reduce chemotherapy induced neutropenia. Pegfilgrastim is only registered for use in adults, but also seems to be safe for children. Lastly, we studied the mortality of non-elective ICU admissions in children with cancer. One of the conclusions of this study is that the survival of these children increased significantly. The second part of this thesis concerns several studies of genetic variants and the risk of developing ALL and (fever during) neutropenia. It was concluded that particular genetic variants that are associated with atopy have an inverse association with ALL.
Last modified: | 13 March 2020 01.02 a.m. |
More news
-
15 May 2024
Part of the children with ADHD can stop using Ritalin sooner
A part of children with ADHD could stop taking Ritalin after two years. This is the conclusion of Anne-Flore Matthijssen's PhD research.
-
13 May 2024
Trapping molecules
In his laboratory, physicist Steven Hoekstra is building an experimental set-up made of two parts: one that produces barium fluoride molecules, and a second part that traps the molecules and brings them to an almost complete standstill so they can...
-
06 May 2024
Impact: 'URinControl', treatment of urine loss through app
One of the three researchers nominated for the Ben Feringa Impact Award 2024 is general practicioner and researcher-epidemiologist Anne Loohuis. Loohuis conducted research on the treatment of urine loss through the self-help app URinControl'.